Sartorius Stedim Biotech S.A.

Factors to consider:

• Company pays dividends (annually): last record date 2025-04-03, amount 0.74$ (Y0.42%)
• Price in estimated range

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2025-12-31 to 2027-12-31

• 2025-12-31 to 2026-12-31 estimated range: [176.10$, 267.38$]
• 2026-12-31 to 2027-12-31 estimated range: [172.54$, 264.00$]

Financial Metrics affecting the SDMHF estimates:

• Negative: with PPE of 75.4 at the end of fiscal year the price was high
• Positive: Operating profit margin, % of 18.50 > 18.38
• Positive: -9.07 < Industry operating profit margin (median), % of -2.56
• Positive: -0.01 < Industry operating cash flow per share per price (median), % of 1.99
• Positive: -4.43 < Investing cash flow per share per price, % of -1.96
• Positive: Inventory ratio change, % of -4.78 <= -0.75
• Negative: 0.73 < Interest expense per share per price, % of 0.75